Becker's Healthcare January 28, 2025
An organization representing Medicare Advantage insurers is asking CMS to pause any policy changes to the program not required by law in 2026.
In a Jan. 28 press release, the Better Medicare Alliance, a pro-MA group backed by several major insurers, urged the agency to prioritize “stability” in its 2026 rules.
In November, the Biden administration pitched several major regulatory changes for 2026, including requiring Medicare to cover GLP-1 drugs for individuals with obesity.
The rule is expected to be finalized by Trump administration officials.
Here are five things to note:
- In a letter to acting CMS Administrator Jeff Wu, the Alliance said it would not comment on the overall proposal to cover GLP-1 drugs, but urged the agency...
Today's Sponsors
Today's Sponsor